Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 May 2025 | Story Vuyelwa Mbebe and Onthatile Tikoe | Photo Hannes Naude
Mthi Mthimkhulu
Mthi Mthimkhulu from the University of the Free State, finishing first in the men’s 400-metre race, surpassing NWU runners-up.

The University of the Free State (UFS) athletics team secured a top five slot at the 2025 University Sports South Africa (USSA) Track and Field Championships, earning fourth place at the event, hosted at the Pilditch Stadium in Pretoria from 1 to 3 May.

University athletes from across South Africa gathered for the championships, which is a key fixture on the USSA calendar. After delivering stellar performances across a broad spectrum of events, UFS went up against 21 other participating universities in various track and field categories.

The standout female athletes at this year’s event were Gabriella Marais, Nicola Gibbon, Lizandré Mulder, and Tyla Wasmüth. Marais scored a first-place finish in the women’s 100-metre race and came second in the women’s 200-metre category. Gibbon, who participated in the women’s 400-metre category, scored third position. Mulder took third and first place in the 5 000-metre and 3 000-metre women’s steeplechase categories respectively. Wasmüth placed in the top three in the women’s shot put and discus throw.

The male athletes who stood out by grabbing first-place wins in their respective categories were Mthi Mthimkhulu in the men’s 400-metre race, Molifi Mohlomi in the men’s 800-metre race, and Wernich van Rensburg in the men’s 400-metre hurdles. Dumisani Motloung took third place in the men’s 1500-metre category, and Samkelo Dlamini took second place for the long jump field sports category.

KovsieSport’s Kesaoleboga Molotsane, UFS Sport Manager for athletics, said the UFS coaching staff need to be kept motivated, as they are the first point of contact with their sports stars. “Unlike team sports, we work with individual athletes who require different and various attention. We only need to motivate the athletes to continue working hard, to study hard, and balance out their responsibilities.” She added that individual performances and athlete placements all helped UFS achieve its overall fourth place at the USSA Championships.

Kovsies can look forward to seeing Mthi Mthimkulu at the World Athletics Relays championships, taking place in China this weekend (10 and 11 May). He’ll be representing South Africa and will be the only Kovsie attending.

Mthimkhulu, Marais, and Van Renburg have also qualified for the upcoming World University Games, to be held in Rhine-Ruhr, Germany, in July. Molotsane encouraged fellow Kovsies to support these and other UFS athletes, whose journeys reflect the spirit of Kovsie athletics.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept